↓ Skip to main content

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

Overview of attention for article published in this source, March 2011
Altmetric Badge

Mentioned by

news
1 news outlet
blogs
1 blog
policy
2 policy sources
twitter
32 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
298 Dimensions

Readers on

mendeley
231 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Published by
John Wiley & Sons, Ltd, March 2011
DOI 10.1002/14651858.cd007938.pub2
Pubmed ID
Authors

Moore, R Andrew, Wiffen, Philip J, Derry, Sheena, McQuay, Henry J

Abstract

This review updates parts of two earlier Cochrane reviews investigating effects of gabapentin in chronic neuropathic pain (pain due to nerve damage). Antiepileptic drugs are used to manage pain, predominantly for chronic neuropathic pain, especially when the pain is lancinating or burning.

X Demographics

X Demographics

The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 231 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 2%
Germany 2 <1%
Norway 1 <1%
Chile 1 <1%
Canada 1 <1%
Egypt 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Other 0 0%
Unknown 218 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 36 16%
Other 30 13%
Student > Master 30 13%
Student > Bachelor 30 13%
Student > Postgraduate 26 11%
Other 57 25%
Unknown 22 10%
Readers by discipline Count As %
Medicine and Dentistry 122 53%
Agricultural and Biological Sciences 17 7%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Nursing and Health Professions 11 5%
Neuroscience 9 4%
Other 33 14%
Unknown 27 12%